Showing posts with label first and only CML therapy with TFR data in product label. Show all posts
Showing posts with label first and only CML therapy with TFR data in product label. Show all posts
Thursday, February 1, 2018

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

›
In continuation of my update on nilotinib Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusi...